Evidence map›Paper›PMID 34400813›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

PPA2-associated sudden cardiac death: extending the clinical and allelic spectrum in 20 new families.

Anne Guimier, Melanie T Achleitner, Anne Moreau de Bellaing, Matthew Edwards, Loïc de Pontual, Kirti Mittal, Kyla E Dunn, Megan E Grove, Carolyn J Tysoe, Clémantine Dimartino and 50 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overview.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. [Molecular medicine: pathobiochemistry as the key to personalized treatment of inherited diseases].Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

60 authors at 20 institutions in 9 countries.

Anne Guimier *INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Melanie T Achleitner *Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
Anne Moreau de BellaingINSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Matthew EdwardsClinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
Loïc de PontualINSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Kirti MittalTranslational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Kyla E DunnChildren's Heart Center, Stanford Children's Health, Palo Alto, CA, USA.
Megan E GroveStanford Medicine Clinical Genomics Program, Stanford, CA, USA.
Carolyn J TysoeExeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Clémantine DimartinoINSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Jessie CameronTranslational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Anil KanthiDepartment of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Anju ShuklaDepartment of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Florence van den BroekDepartment of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
Diptendu ChatterjeeTranslational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Charlotte L AlstonWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Charlotte V KnowlesWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Laura BrettClinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
Jan A TillPaediatric Cardiology, Royal Brompton and Harefield NHS Trust, London, UK.
Tessa HomfrayClinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
Paul FrenchWest of Scotland Centre for Genomic Medicine, Queen Elizabeth University Hospital, Glasgow, UK.
Georgia SpentzouThe Royal Hospital for Children, Glasgow, UK.
Noha A ElserafyGenetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
Kate S LichkusGenetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
Bindu P SankaranGenetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
Hannah L KennedyDepartment of Psychological Medicine, University of Otago, Christchurch, New Zealand.
Peter M GeorgePathogene, Christchurch, New Zealand.
Alexa KiddClinical Genetics New Zealand, Christchurch, New Zealand.
Saskia B WortmannDepartment of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria.
Dianna G FiskStanford Medicine Clinical Genomics Program, Stanford, CA, USA.
Tamara T KoopmannTranslational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Muhammad A RafiqTranslational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Jason D MerkerDepartment of Pathology, School of Medicine, Stanford, CA, USA.
Sumith ParikhMitochondrial Medicine Center, Neuroscience Institute, Cleveland Clinic, Cleveland, OH, USA.
Priyanka AhimazDepartment of Pediatrics, Columbia University, New York, NY, USA.
Robert G WeintraubThe Royal Children's Hospital Melbourne, Melbourne, VIC, Australia.
Alan S MaDepartment of Clinical Genetics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Christian TurnerHeart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia.
Carolyn J EllawayGenetic Metabolic Disorders Service, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Sydney, NSW, Australia.
Liza K PhillipsSA Pathology, Department of Genetics and Molecular Pathology, Adelaide, SA, Australia.
David R ThorburnMurdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, Australia.
Wendy K ChungDepartment of Pediatrics, Columbia University, New York, NY, USA.
Sajel L KanaDivision of Clinical Genetics and Metabolism, Nicklaus Children's Health System, Miami, FL, USA.
Ona M Faye-PetersenDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Michelle L ThompsonHudson Alpha Institute for Biotechnology, Huntsville, AL, USA.
Alexandre JaninLaboratoire de Cardiogénétique Moléculaire, Service de Biochimie et Biologie Moléculaire, Hospices Civils de Lyon, Lyon, France.
Karen McLeodThe Royal Hospital for Children, Glasgow, UK.
Ruth McGowanWest of Scotland Centre for Genomic Medicine, Queen Elizabeth University Hospital, Glasgow, UK.
Robert McFarlandWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Katta M GirishaDepartment of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Deborah J Morris-RosendahlClinical Genetics and Genomics Laboratory, Royal Brompton and Harefield NHS Trust, London, UK.
Anna C E HurstDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Claire L S TurnerDepartment of Clinical Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Robert M HamiltonTranslational Medicine program and the Genetics & Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada.
Robert W TaylorWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Fanny BajolleUnité médico-chirurgicale de cardiologie pédiatrique, Hôpital Necker Enfants Malades, APHP, Paris, France.
Christopher T Gordon *INSERM U1163, Université de Paris, Institut Imagine, Paris, France.
Jeanne Amiel *INSERM U1163, Université de Paris, Institut Imagine, Paris, France. jeanne.amiel@inserm.fr.
Johannes A Mayr *Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria. h.mayr@salk.at.
Kit Doudney *Centre for Postgraduate Nursing Studies and the Department of Pathology and Biomedical Science, University of Otago Christchurch, Otautahi, New Zealand. kit.doudney@otago.ac.nz.
Hospital for Sick Children · CARoyal Brompton & Harefield NHS Foundation Trust · GBNewcastle University · GBParacelsus Medical University · ATRoyal Devon & Exeter NHS Foundation Trust · GBSydney Children’s Hospitals Network · AUAssistance Publique – Hôpitaux de Paris · FRChildren's Hospital at Westmead · AUInserm · FRInstitut des Maladies Génétiques Imagine · FRKasturba Medical College, Manipal · INNew York University · USQueen Elizabeth University Hospital · GBStanford Medicine · USUniversity of Alabama at Birmingham · USUniversity of Otago · NZCleveland Clinic · USClinical Trials New Zealand · NZColumbia University · USFlorida International University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
Genetic Diagnosis of Neurodevelopmental Disorders in IndiaR01HD093570 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BIELAS, STEPHANIE LEE · 2018 to 2024
$2.3M
Biotechnology and Biological Sciences Research Council G016354/1NCATS NIH HHS UL1 TR001863NHGRI NIH HHS U01 HG007301NICHD NIH HHS R01 HD093570Wellcome TrustWellcome Trust Centre for Mitochondrial Research 203105/Z/16/Z
6 · The paper itself

Abstract

purposeBiallelic hypomorphic variants in PPA2, encoding the mitochondrial inorganic pyrophosphatase 2 protein, have been recently identified in individuals presenting with sudden cardiac death, occasionally triggered by alcohol intake or a viral infection. Here we report 20 new families harboring PPA2 variants.

methodsSynthesis of clinical and molecular data concerning 34 individuals harboring five previously reported PPA2 variants and 12 novel variants, 11 of which were functionally characterized.

resultsAmong the 34 individuals, only 6 remain alive. Twenty-three died before the age of 2 years while five died between 14 and 16 years. Within these 28 cases, 15 died of sudden cardiac arrest and 13 of acute heart failure. One case was diagnosed prenatally with cardiomyopathy. Four teenagers drank alcohol before sudden cardiac arrest. Progressive neurological signs were observed in 2/6 surviving individuals. For 11 variants, recombinant PPA2 enzyme activities were significantly decreased and sensitive to temperature, compared to wild-type PPA2 enzyme activity.

conclusionWe expand the clinical and mutational spectrum associated with PPA2 dysfunction. Heart failure and sudden cardiac arrest occur at various ages with inter- and intrafamilial phenotypic variability, and presentation can include progressive neurological disease. Alcohol intake can trigger cardiac arrest and should be strictly avoided.

Indexed as

CardiomyopathiesDeath, Sudden, CardiacAdolescentAllelesChild, PreschoolHumansInorganic PyrophosphataseMitochondrial ProteinsMutationInorganic PyrophosphataseMitochondrial ProteinsPPA2 protein, human

Identifiers

PMID34400813
PMCPMC8629752
OpenAlexW3195316810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.